Showing results (51-60 of 126) with videos related to
Sort By:
Pageof 13
Molecular and Cellular Biology|April 6, 2011
Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoterHideto Tozawa, Yasuharu Kanki, Jun-ichi Suehiro, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2008
Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patientsRyozo Nagai, Tohru Izumi, Masahiko Kurabayashi, et al.Atherosclerosis|January 7, 2012
Prognostic implication of macrocytosis on adverse outcomes after coronary interventionMasahiro Myojo, Hiroshi Iwata, Takahide Kohro, et al.Lipids in Health and Disease|June 26, 2017
Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjectsKentaro Sakamoto, Mitsunobu Kawamura, Takayuki Watanabe, et al.Transplantation|May 23, 2002
Detection of an up-regulation of a group of chemokine genes in murine cardiac allograft in the absence of interferon-gamma by means of DNA microarrayAkio Saiura, Takahide Kohro, Takashi Yamamoto, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|November 19, 2008
Elevated serum C-reactive protein levels predict cardiovascular events in the Japanese coronary artery disease (JCAD) studyKenei Shimada, Masatoshi Fujita, Atsushi Tanaka, et al.Lipids in Health and Disease|October 8, 2013
RESEARCH (Recognized effect of Statin and ezetimibe therapy for achieving LDL-C Goal), a randomized, doctor-oriented, multicenter trial to compare the effects of higher-dose statin versus ezetimibe-plus-statin on the serum LDL-C concentration of Japanese type-2 diabetes patients design and rationaleTakeshi Inazawa, Kentaro Sakamoto, Takahide Kohro, et al.Journal of Atherosclerosis and Thrombosis|January 14, 2004
Global analysis of shear stress-responsive genes in vascular endothelial cellsNorihiko Ohura, Kimiko Yamamoto, Sigeru Ichioka, et al.The Journal of Biological Chemistry|September 28, 2004
Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesisTakashi Minami, Keiko Horiuchi, Mai Miura, et al.International Heart Journal|February 26, 2019
Architecture of the Japan Ischemic Heart Disease Multimodal Prospective Data Acquisition for Precision Treatment (J-IMPACT) SystemTetsuya Matoba, Takahide Kohro, Hideo Fujita, et al.Pageof 13